AbbVie Inc.

Registered sites: 13
Drug products: 129
Live patents: 464
Countries: 5
Base: United States

Authorisation

Registered operations

What the FDA has registered these sites to do. This is the regulatory record, not a marketing claim.

Analytical testingActive ingredient (API) manufactureLabellingFinished drug manufacturePackaging

Sites

Facilities

Site	Location	Operations	FEI
AbbVie Biotechnology GmbH	LudwigshafenGermany	Analytical testing	3011277200
AbbVie Deutschland GmbH & Co KG	LudwigshafenGermany	Analytical testing, Labelling, Finished drug manufacture, Packaging	3002807401
Fournier Laboratories Ireland Limited	CARRIGTWOHILLIreland	Analytical testing, Finished drug manufacture	3004134577
AbbVie Ireland NL B.V.	SligoIreland	Analytical testing, Active ingredient (API) manufacture, Finished drug manufacture	3004364014
AbbVie Ireland NL. B.V.	SligoIreland	Finished drug manufacture	3012441529
AbbVie SRL	Campoverde di ApriliaItaly	Analytical testing, Active ingredient (API) manufacture, Labelling, Finished drug manufacture, Packaging	3002806277
AbbVie Operations Singapore Pte. Ltd.	SingaporeSingapore	Analytical testing, Active ingredient (API) manufacture	3011774256
AbbVie Biotechnology LTD	Barceloneta, PRUnited States	Analytical testing, Active ingredient (API) manufacture, Finished drug manufacture	3004620772
AbbVie Ltd	Barceloneta, PRUnited States	Analytical testing, Labelling, Finished drug manufacture, Packaging	3000210838
AbbVie Inc.	North Chicago, ILUnited States	Analytical testing, Labelling, Finished drug manufacture, Packaging	3009751352
AbbVie Inc.	North Chicago, ILUnited States	Analytical testing, Active ingredient (API) manufacture, Finished drug manufacture	1411365
AbbVie Bioresearch Center	Worcester, MAUnited States	Analytical testing, Active ingredient (API) manufacture, Finished drug manufacture	3003684386
AbbVie Inc.	Wyandotte, MIUnited States	Analytical testing, Active ingredient (API) manufacture	3010166391

Exclusivity

Patents

464

Unexpired Orange Book patents where this company is the application holder.

Product	Active ingredient	Expiry
ACULAR LS	KETOROLAC TROMETHAMINE	May 2027
ACULAR LS	KETOROLAC TROMETHAMINE	Nov 2027
ACUVAIL	KETOROLAC TROMETHAMINE	Mar 2028
ACUVAIL	KETOROLAC TROMETHAMINE	Aug 2029
AVYCAZ	AVIBACTAM SODIUM; CEFTAZIDIME	Nov 2026
AVYCAZ	AVIBACTAM SODIUM; CEFTAZIDIME	Oct 2030
AVYCAZ	AVIBACTAM SODIUM; CEFTAZIDIME	Aug 2031
AVYCAZ	AVIBACTAM SODIUM; CEFTAZIDIME	Jun 2032
BYVALSON	NEBIVOLOL HYDROCHLORIDE; VALSARTAN	Aug 2026
BYVALSON	NEBIVOLOL HYDROCHLORIDE; VALSARTAN	Oct 2027
CANASA	MESALAMINE	Jun 2028
DALVANCE	DALBAVANCIN HYDROCHLORIDE	May 2028
DURYSTA	BIMATOPROST	Dec 2026
DURYSTA	BIMATOPROST	Apr 2027
DURYSTA	BIMATOPROST	Apr 2029
DURYSTA	BIMATOPROST	Jul 2031
DURYSTA	BIMATOPROST	Oct 2034
EMBLAVEO	AVIBACTAM SODIUM; AZTREONAM	Nov 2026
EMBLAVEO	AVIBACTAM SODIUM; AZTREONAM	Oct 2030
EMBLAVEO	AVIBACTAM SODIUM; AZTREONAM	Aug 2031
EMBLAVEO	AVIBACTAM SODIUM; AZTREONAM	Jun 2032
FETZIMA	LEVOMILNACIPRAN HYDROCHLORIDE	Mar 2031
FETZIMA	LEVOMILNACIPRAN HYDROCHLORIDE	May 2032
GELNIQUE	OXYBUTYNIN CHLORIDE	Nov 2029
GELNIQUE	OXYBUTYNIN CHLORIDE	Mar 2031
KYBELLA	DEOXYCHOLIC ACID	Dec 2027
KYBELLA	DEOXYCHOLIC ACID	Feb 2028
KYBELLA	DEOXYCHOLIC ACID	May 2028
KYBELLA	DEOXYCHOLIC ACID	Mar 2030
KYBELLA	DEOXYCHOLIC ACID	Feb 2032
LASTACAFT	ALCAFTADINE	Mar 2027
LASTACAFT	ALCAFTADINE	Dec 2027
LINZESS	LINACLOTIDE	Aug 2026
LINZESS	LINACLOTIDE	Feb 2027
LINZESS	LINACLOTIDE	Feb 2031
LINZESS	LINACLOTIDE	Aug 2031
LINZESS	LINACLOTIDE	Aug 2031
LINZESS	LINACLOTIDE	Oct 2031
LINZESS	LINACLOTIDE	Feb 2032
LINZESS	LINACLOTIDE	Apr 2032
LINZESS	LINACLOTIDE	Aug 2033
LINZESS	LINACLOTIDE	Feb 2034
LUMIGAN	BIMATOPROST	Jun 2027
MAVYRET	GLECAPREVIR; PIBRENTASVIR	Jun 2030
MAVYRET	GLECAPREVIR; PIBRENTASVIR	Nov 2030
MAVYRET	GLECAPREVIR; PIBRENTASVIR	Dec 2030
MAVYRET	GLECAPREVIR; PIBRENTASVIR	May 2031
MAVYRET	GLECAPREVIR; PIBRENTASVIR	Jan 2032
MAVYRET	GLECAPREVIR; PIBRENTASVIR	May 2032
MAVYRET	GLECAPREVIR; PIBRENTASVIR	Jul 2032
MAVYRET	GLECAPREVIR; PIBRENTASVIR	Nov 2032
MAVYRET	GLECAPREVIR; PIBRENTASVIR	Mar 2034
MAVYRET	GLECAPREVIR; PIBRENTASVIR	Sept 2034
MAVYRET	GLECAPREVIR; PIBRENTASVIR	May 2035
MAVYRET	GLECAPREVIR; PIBRENTASVIR	Jun 2035
MAVYRET	GLECAPREVIR; PIBRENTASVIR	Nov 2035
MAVYRET	GLECAPREVIR; PIBRENTASVIR	Dec 2035
MAVYRET	GLECAPREVIR; PIBRENTASVIR	Jun 2036
MAVYRET	GLECAPREVIR; PIBRENTASVIR	Dec 2036
NAMENDA XR	MEMANTINE HYDROCHLORIDE	Mar 2029

Catalogue

Marketed products

129

Showing 129 of 129.

Brand	Generic name	Form	Category
-	Adalimumab	LIQUID	BULK INGREDIENT
Creon	Pancrelipase	CAPSULE, DELAYED RELEASE	BLA
Creon	Pancrelipase	CAPSULE, DELAYED RELEASE PELLETS	BLA
Creon	Pancrelipase	CAPSULE, DELAYED RELEASE PELLETS	BLA
Creon	Pancrelipase	CAPSULE, DELAYED RELEASE	BLA
Creon	Pancrelipase	CAPSULE, DELAYED RELEASE PELLETS	BLA
Creon	Pancrelipase	CAPSULE, DELAYED RELEASE PELLETS	BLA
Creon	Pancrelipase	CAPSULE, DELAYED RELEASE PELLETS	BLA
Creon	Pancrelipase	CAPSULE, DELAYED RELEASE PELLETS	BLA
Creon	Pancrelipase	CAPSULE, DELAYED RELEASE PELLETS	BLA
Creon	Pancrelipase	CAPSULE, DELAYED RELEASE PELLETS	BLA
-	Cyclosporine	POWDER	BULK INGREDIENT
DECNUPAZ	pivekimab sunirine-pvzy	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	BLA
Depakote	Divalproex Sodium	TABLET, DELAYED RELEASE	NDA
Depakote	Divalproex Sodium	TABLET, DELAYED RELEASE	NDA
Depakote	Divalproex Sodium	TABLET, DELAYED RELEASE	NDA
Depakote ER	Divalproex Sodium	TABLET, EXTENDED RELEASE	NDA
Depakote ER	Divalproex Sodium	TABLET, EXTENDED RELEASE	NDA
Depakote Sprinkles	Divalproex Sodium	CAPSULE	NDA
Duopa	Carbidopa and Levodopa	SUSPENSION	NDA
EMBLAVEO	aztreonam and avibactam	POWDER, FOR SOLUTION	NDA
EMRELIS	Telisotuzumab Vedotin	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	BLA
EMRELIS	Telisotuzumab Vedotin	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	BLA
-	Elagolix Sodium	POWDER	BULK INGREDIENT
-	Foscarbidopa	POWDER	BULK INGREDIENT
-	Foslevodopa	POWDER	BULK INGREDIENT
Gengraf	Cyclosporine	CAPSULE	ANDA
Gengraf	Cyclosporine	CAPSULE	ANDA
Humira	Adalimumab	KIT	BLA
Humira	Adalimumab	KIT	BLA
Humira	Adalimumab	KIT	BLA
Humira	Adalimumab	KIT	BLA
Humira	Adalimumab	KIT	BLA
Humira	Adalimumab	KIT	BLA
Humira	Adalimumab	KIT	BLA
Humira	Adalimumab	KIT	BLA
Humira	Adalimumab	KIT	BLA
-	Ibrutinib	CAPSULE	DRUG FOR FURTHER PROCESSING
-	Ibrutinib	CAPSULE	DRUG FOR FURTHER PROCESSING
Kaletra	Lopinavir and Ritonavir	TABLET, FILM COATED	NDA
Kaletra	Lopinavir and Ritonavir	SOLUTION	NDA
Kaletra	Lopinavir and Ritonavir	TABLET, FILM COATED	NDA
Lupron Depot	leuprolide acetate	KIT	NDA
Lupron Depot	leuprolide acetate	KIT	NDA
Lupron Depot	leuprolide acetate	KIT	NDA
Lupron Depot	leuprolide acetate	KIT	NDA
Lupron Depot	leuprolide acetate	KIT	NDA
Lupron Depot	leuprolide acetate	KIT	NDA
Lupron Depot-PED	leuprolide acetate	KIT	NDA
Lupron Depot-PED	leuprolide acetate	KIT	NDA
Lupron Depot-PED	leuprolide acetate	KIT	NDA
Lupron Depot-PED	leuprolide acetate	KIT	NDA
Lupron Depot-PED	leuprolide acetate	KIT	NDA
Lupron Depot-PED	leuprolide acetate	KIT	NDA
Mavyret	Glecaprevir and Pibrentasvir	PELLET	NDA
Mavyret	Glecaprevir and Pibrentasvir	TABLET, FILM COATED	NDA
Norvir	Ritonavir	TABLET, FILM COATED	NDA
Norvir	Ritonavir	POWDER	NDA
-	Olaparib	TABLET, FILM COATED	DRUG FOR FURTHER PROCESSING
-	Olaparib	TABLET, FILM COATED	DRUG FOR FURTHER PROCESSING
Oriahnn	Elagolix and Estradiol and Norethisterone	KIT	NDA
Orilissa	Elagolix	TABLET, FILM COATED	NDA
Orilissa	Elagolix	TABLET, FILM COATED	NDA
Qulipta	Atogepant	TABLET	NDA
Qulipta	Atogepant	TABLET	NDA
Qulipta	Atogepant	TABLET	NDA
-	RISANKIZUMAB	INJECTION, SOLUTION	DRUG FOR FURTHER PROCESSING
Rinvoq	Upadacitinib	TABLET, EXTENDED RELEASE	NDA
Rinvoq	Upadacitinib	TABLET, EXTENDED RELEASE	NDA
Rinvoq	Upadacitinib	TABLET, EXTENDED RELEASE	NDA
Rinvoq	Upadacitinib	SOLUTION	NDA
-	Risankizumab	LIQUID	BULK INGREDIENT
-	Risankizumab	LIQUID	BULK INGREDIENT
-	Risankizumab	INJECTION, SOLUTION	DRUG FOR FURTHER PROCESSING
-	Risankizumab	INJECTION, SOLUTION	DRUG FOR FURTHER PROCESSING
-	Risankizumab	INJECTION, SOLUTION	DRUG FOR FURTHER PROCESSING
-	Risankizumab	INJECTION, SOLUTION	DRUG FOR FURTHER PROCESSING
-	Risankizumab	LIQUID	DRUG FOR FURTHER PROCESSING
-	SOTATERCEPT	LIQUID	BULK INGREDIENT
Skyrizi	risankizumab-rzaa	INJECTION	BLA
Skyrizi	Risankizumab-rzaa	KIT	BLA
Skyrizi	Risankizumab-rzaa	KIT	BLA
Skyrizi	risankizumab-rzaa	INJECTION	BLA
Skyrizi	risankizumab-rzaa	INJECTION, SOLUTION	BLA
Skyrizi	risankizumab-rzaa	INJECTION	BLA
Skyrizi	Risankizumab-rzaa	KIT	BLA
Skyrizi	Risankizumab-rzaa	KIT	BLA
Skyrizi	risankizumab-rzaa	INJECTION	BLA
Skyrizi	risankizumab-rzaa	INJECTION	BLA
Survanta	Beractant	SUSPENSION	BLA
Synthroid	Levothyroxine Sodium	TABLET	NDA
Synthroid	Levothyroxine Sodium	TABLET	NDA
Synthroid	Levothyroxine Sodium	TABLET	NDA
Synthroid	Levothyroxine Sodium	TABLET	NDA
Synthroid	Levothyroxine Sodium	TABLET	NDA
Synthroid	Levothyroxine Sodium	TABLET	NDA
Synthroid	Levothyroxine Sodium	TABLET	NDA
Synthroid	Levothyroxine Sodium	TABLET	NDA
Synthroid	Levothyroxine Sodium	TABLET	NDA
Synthroid	Levothyroxine Sodium	TABLET	NDA
Synthroid	Levothyroxine Sodium	TABLET	NDA
Synthroid	Levothyroxine Sodium	TABLET	NDA
Ultane	Sevoflurane	LIQUID	NDA
-	Upadacitinib	TABLET	DRUG FOR FURTHER PROCESSING
-	Upadacitinib	TABLET, EXTENDED RELEASE	DRUG FOR FURTHER PROCESSING
-	Upadacitinib	POWDER	BULK INGREDIENT
VUITY	Pilocarpine Hydrochloride	SOLUTION/ DROPS	NDA
-	Valproate Semisodium	CAPSULE	EXPORT ONLY
-	Vedolizumab	LIQUID	BULK INGREDIENT
Venclexta	Venetoclax	TABLET, FILM COATED	NDA
Venclexta	Venetoclax	TABLET, FILM COATED	NDA
Venclexta	Venetoclax	TABLET, FILM COATED	NDA
Venclexta	Venetoclax	KIT	NDA
-	Venetoclax	POWDER	DRUG FOR FURTHER PROCESSING
-	Venetoclax	TABLET	DRUG FOR FURTHER PROCESSING
Vyalev	foscarbidopa/foslevodopa	INJECTION	NDA
Zemplar	Paricalcitol	INJECTION, SOLUTION	NDA
Zemplar	Paricalcitol	INJECTION, SOLUTION	NDA
Zemplar	Paricalcitol	CAPSULE, LIQUID FILLED	NDA
Zemplar	Paricalcitol	CAPSULE, LIQUID FILLED	NDA
-	adalimumab	INJECTION, SOLUTION	DRUG FOR FURTHER PROCESSING
-	adalimumab	INJECTION, SOLUTION	DRUG FOR FURTHER PROCESSING
-	adalimumab	INJECTION, SOLUTION	DRUG FOR FURTHER PROCESSING
-	atogepant	TABLET	DRUG FOR FURTHER PROCESSING
-	atogepant	TABLET	DRUG FOR FURTHER PROCESSING
-	atogepant	TABLET	DRUG FOR FURTHER PROCESSING
-	upadacitinib	TABLET	DRUG FOR FURTHER PROCESSING
-	venetoclax	TABLET, FILM COATED	DRUG FOR FURTHER PROCESSING
-	venetoclax	TABLET, FILM COATED	DRUG FOR FURTHER PROCESSING

Provenance

Facility and operations data from the FDA Drug Establishments Current Registration Site. Product data from the openFDA National Drug Code Directory. Patent and exclusivity data from the FDA Orange Book. Shortage data from the FDA drug shortage database. Contact details the FDA publishes for registered establishments are deliberately not reproduced here. This entry is compiled from public records and has not been claimed by the company.